CENTOGENE NV
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CENTOGENE NV and buy or sell other stocks, ETFs, and their options commission-free!About CNTGF
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate.
CEODavid Jiménez
CEODavid Jiménez
Employees493
Employees493
HeadquartersRostock, Mecklenburg-Vorpommern
HeadquartersRostock, Mecklenburg-Vorpommern
Founded2018
Founded2018
Employees493
Employees493
CNTGF Key Statistics
Market cap4.21M
Market cap4.21M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume3.28K
Average volume3.28K
High today$0.145
High today$0.145
Low today$0.145
Low today$0.145
Open price$0.145
Open price$0.145
Volume1.50K
Volume1.50K
52 Week high$0.5501
52 Week high$0.5501
52 Week low$0.0376
52 Week low$0.0376
People also own
Based on the portfolios of people who own CNTGF. This list is generated using Robinhood data, and it’s not a recommendation.